Search results
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 3 days agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...
SciTech Development secures additional funding for cancer trials
Clinical Trials Arena via Yahoo Finance· 4 days agoThe US Food and Drug Administration (FDA) previously granted orphan drug designation to ST-001,...
Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon
Zacks via Yahoo Finance· 1 day agoIn Breast Health, Hologic broadened its product offering from imaging to cover the entire breast ...
I’m an oncologist. Here’s what I advised my mom after her cancer diagnosis. | Expert Opinion
Philly.com· 1 day agoQ: My mother-in-law was recently diagnosed with cancer. What steps should patients like her take to...
Lack of insurance keeps many Americans from best cancer meds
Medical Xpress· 5 days agoNew policies are needed "to improve health insurance coverage options and to make new treatments...
Can Finasteride Help With My Particular Type of Hair Loss? Everything You Need to Know
AOL· 13 hours agoIf you’ve been looking into Propecia or its generic finasteride, for hair loss, you probably have many questions. Finasteride is a popular and safe medication for hair loss that is effective for many men with few adverse effects.
Cancer treatment is becoming more effective and tolerable
WGRZ-TV Buffalo· 6 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
What’s keeping the U.S. from allowing better sunscreens?
Arizona Daily Sun· 5 days agoWhen dermatologist Adewole “Ade” Adamson sees people spritzing sunscreen as if it’s cologne at the...
Is It Time to Dump Your Toothpaste?
Mercola· 17 hours agoWith this in mind, it's worth considering what you and your children are placing in your mouth on a daily basis. Unfortunately, as toothpaste falls under the category of cosmetics,4 manufacturers ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
